These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 24787449)
1. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype. Relling MV; McDonagh EM; Chang T; Caudle KE; McLeod HL; Haidar CE; Klein T; Luzzatto L; Clin Pharmacol Ther; 2014 Aug; 96(2):169-74. PubMed ID: 24787449 [TBL] [Abstract][Full Text] [Related]
2. Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype. Gammal RS; Pirmohamed M; Somogyi AA; Morris SA; Formea CM; Elchynski AL; Oshikoya KA; McLeod HL; Haidar CE; Whirl-Carrillo M; Klein TE; Caudle KE; Relling MV Clin Pharmacol Ther; 2023 May; 113(5):973-985. PubMed ID: 36049896 [TBL] [Abstract][Full Text] [Related]
3. Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6- Phosphate Dehydrogenase Deficiency. Khan M; Paul S; Farooq S; Oo TH; Ramshesh P; Jain N Curr Drug Saf; 2017; 12(1):13-18. PubMed ID: 28078984 [TBL] [Abstract][Full Text] [Related]
4. Methemoglobinemia induced by rasburicase in a pediatric patient: a case report and literature review. Ng JS; Edwards EM; Egelund TA J Oncol Pharm Pract; 2012 Dec; 18(4):425-31. PubMed ID: 22190578 [TBL] [Abstract][Full Text] [Related]
5. Hemolysis and methemoglobinemia secondary to rasburicase administration. Browning LA; Kruse JA Ann Pharmacother; 2005 Nov; 39(11):1932-5. PubMed ID: 16204390 [TBL] [Abstract][Full Text] [Related]
6. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency. Belfield KD; Tichy EM Am J Health Syst Pharm; 2018 Feb; 75(3):97-104. PubMed ID: 29305344 [TBL] [Abstract][Full Text] [Related]
7. Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency. Cheah CY; Lew TE; Seymour JF; Burbury K Acta Haematol; 2013; 130(4):254-9. PubMed ID: 23860572 [TBL] [Abstract][Full Text] [Related]
8. Impact of pre-emptive rapid testing for glucose-6-phosphate dehydrogenase deficiency prior to rasburicase administration at a tertiary care centre: A retrospective study. Ganapathi M; Campbell P; Ofori K; Aggarwal V; Francis RO; Kratz A Br J Clin Pharmacol; 2022 Sep; 88(9):4163-4170. PubMed ID: 35419830 [TBL] [Abstract][Full Text] [Related]
9. I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency. Reeves DJ; Saum LM; Birhiray R Am J Health Syst Pharm; 2016 May; 73(9):e238-42. PubMed ID: 27099330 [TBL] [Abstract][Full Text] [Related]